Journey Clinical
PrivateLast Round
Series A
Jan 24, 2023
Total Funding Raised
$11.5M
Company Overview
Journey Clinical operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in January 2023.
Journey Clinical is a healthtech company that provides a platform for licensed mental health professionals to deliver Psychedelic-Assisted Psychotherapy (PAP), starting with Ketamine-Assisted Psychotherapy (KAP).
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Journey Clinical Comparables
Compare Journey Clinical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Ko-Op | 78% | |
| Osmind | 76% | |
| Psychedelic Support, Inc. | 73% |
For institutional investors. Book with your work email.
Journey Clinical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 24, 2023 | ||||
| Seed | Sep 30, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Journey Clinical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Series A |
| Able Partners | Series A |
| Union Square Ventures | Series A |
| Gaingels | Series A, Seed |
| Lionheart Ventures | Seed |
| Mystic Ventures | Series A |
| Palo Santo | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Offering in-person monitoring for Spravato® treatments.
- Oct 15, 2025
Will provide Ketamine-Assisted Psychotherapy (KAP) education for group members.
For institutional investors. Book with your work email.
Journey Clinical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Journey Clinical's valuation, stock price, and market status.
Is Journey Clinical a public or private company?
Journey Clinical is a private company.
What is the current stock price of Journey Clinical?
Journey Clinical is a private company, so its shares have no public market price. Caplight tracks Journey Clinical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Journey Clinical worth (valuation)?
Valuation information for Journey Clinical is not publicly available.
Can I buy Journey Clinical stock?
Journey Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Journey Clinical's last funding round?
Journey Clinical's most recent funding round was Series A on January 24, 2023.
Who are the main investors in Journey Clinical?
Key investors in Journey Clinical include Union Square Ventures, Fifty Years.
Will Journey Clinical IPO soon?
No public IPO plans have been announced for Journey Clinical.
How can I track Journey Clinical secondary market activity?
Caplight tracks bids, offers, and trades in Journey Clinical's shares on secondary markets.